You searched for "AMM"

2004 results found

Renewed momentum in ocular gene and cell therapy, broadening application to chronic disease

Gene and cell therapies offer the prospect of ground-breaking new avenues for the treatment of diseases, reflected in a renewed explosion of interest and investment in retinal gene therapy. Rod McNeil reports recent clinical trial readouts across a diverse range...

Aniridia Network 2023 Conference: Amy's experience as a first-time attendee

I have lived with aniridia since birth; and no matter how many specialised doctors you see or how many other people with visual impairments you meet, you still feel isolated, different and misunderstood. This is the exact reason Aniridia Network is important.

Age and gender impacts effectiveness of new gene therapy treatments for eye diseases, new study finds

Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found. The University of Bristol-led study, published in Molecular Therapy, reveal how age and gender affects inflammation caused by gene...

RCOphth 2024 Preview

Here is our annual highlights preview of the upcoming RCOphth 2024 Annual Congress in Belfast's ICC, 20-23 May.

Improved efficacy expected with second-generation microinvasive glaucoma surgery (MIGS) devices

Microinvasive surgical approaches to primary open-angle glaucoma (POAG) offer minimally traumatic options for effective intraocular pressure (IOP) reduction in appropriately selected glaucoma patients. Increases in laser trabeculoplasty rates and wider adoption of glaucoma drainage device filtration procedures, together with the...

My top five: Trinkets of fact or fiction

Trinkets of adult wisdom are often delivered to children alongside warnings of catastrophic outcomes. In this article we present five ‘facts’ about eye health and vision and ask the question: to what extent are these ideas backed up by literature?...

My Top Five: Trinkets of fact or fiction

Trinkets of adult wisdom are often delivered to children alongside warnings of catastrophic outcomes. In this article we present five ‘facts’ about eye health and vision and ask the question: to what extent are these ideas backed up by literature?...

Redefining healthcare through the eyes

The future of healthcare is being shaped by innovation in eyecare and in particular a field known as oculomics. This discipline leverages ocular biomarkers to provide insights into various health conditions, including cardiovascular diseases and psychological or neurological disorders [1]....

Lost in translation

The article that follows is a collection of reflections and observations by Peter (British) and Nathan (Singaporean) living and working in each other’s countries. Peter Cackett “Best thing about this place is it’s not still full of pompous ex-colonials who...

Intraocular lens choice in patients who have undergone previous corneal refractive surgery

Patients who underwent vision correction in their 20s to 40s are now entering their 50s and 60s, the typical starting age for cataract development [1]. Consequently, ophthalmologists are increasingly encountering patients whose corneal profiles have been surgically altered, requiring advanced...

XXI SARCS (State of the Art Refractive Cataract Surgery) Symposium 2023

You are invited to XXI State of the Art Refractive and Cataract Surgery Symposium on Friday 16 June 2023 at the University of Hull. This is the place where brilliant minds from around the world come together to share their...

The Oxford Ophthalmological Congress CIO (the OOC): Invitation to Tender for Conference Organisation & Event Management Services

The Oxford Ophthalmological Congress CIO (the OOC)Charity no. 1181776Invitation to Tender for Conference Organisation & Event Management Services The Oxford Ophthalmological Congress is an historic meeting, in its 103rd year, and the second largest ophthalmological meeting held in the UK....